Aberrant Frequency of IL-10-Producing B Cells and Its Association with Treg/Th17 in Adult Primary Immune Thrombocytopenia Patients

Table 1

Clinical characteristics of ITP patients.

Patient number	Sex	Age (years)	Duration of disease (months)^∗	Platelet counts (×10^9/L)		Response to first-line therapies
				Before treatment	After treatment
1	F	56	6	8	6	NR
2	F	28	8	11	56	PR
3	M	38	2	12	26	NR
4	F	63	1	18	84	PR
5	F	47	12	9	45	PR
6	F	67	5	2	169	CR
7	M	46	20	8	227	CR
8	F	52	1	13	175	CR
9	M	19	18	7	239	CR
10	F	34	14	3	18	NR
11	M	41	7	17	157	CR
12	F	68	21	6	193	CR
13	F	43	2	5	296	CR
14	F	36	4	12	137	CR
15	F	50	14	14	15	NR
16	F	79	4	4	46	PR
17	M	35	1	1	6	NR
18	F	38	5	8	186	CR
19	F	59	9	15	24	NR
20	F	67	32	22	47	PR
21	M	33	1	3	134	CR
22	F	73	15	18	214	CR
23	M	24	1	7	151	CR
24	F	24	1	6	86	PR
25	F	50	4	8	65	PR
26	M	50	20	12	26	NR
27	F	30	12	8	38	PR
28	F	28	8	16	64	PR
29	M	46	32	20	84	PR
30	F	54	16	13	23	NR
31	M	62	2	7	141	CR
32	F	49	6	11	137	CR
33	F	35	10	3	192	CR
34	F	37	1	12	179	CR
35	F	51	4	17	231	CR
Median	—	46	6	9	137	—
(Min.–max.)	—	(19–79)	(1–32)	(1–22)	(6–296)	—

∗Approximately estimated according to initial manifestation of bleeding symptoms and/or platelet count <100 (×10⁹/L).